Edvard Skripochnik, MD
Vascular Surgery · Bronx, NYNPI 1902291289
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $102,695 of the $158,308 with a category attached, or 64.9%. Terumo Medical Corporation accounts for 63.0% of it on its own, with 28 other manufacturers making up the rest. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 374 payments — averaging $423.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Terumo Medical Corporation$100K
- Inari Medical, Inc.$22K
- Angiodynamics, Inc.$15K
- Cook Incorporated$10K
- W. L. Gore & Associates, Inc.$4K
- Shape Memory Medical Inc.$2K
- plus $7K from 23 others
Across 131 payments — averaging $1879.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$183K
- Vesper Medical$39K
- Philips North America LLC$19K
- Stryker$5K
What the payments were for
- Consulting fees$102,69565%
- Speaking & faculty fees$15,70010%
- Travel & lodging$13,6809%
- Food & beverage$11,9538%
- Education$1,2001%
- Other$13,0808%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Terumo Medical Corporation | 114 | $99,800 |
| Inari Medical, Inc. | 72 | $21,530 |
| Angiodynamics, Inc. | 24 | $14,549 |
| Cook Incorporated | 8 | $9,581 |
| W. L. Gore & Associates, Inc. | 14 | $3,606 |
| Shape Memory Medical Inc. | 10 | $1,982 |
| Bolton Medical Inc | 7 | $1,910 |
| Cook Medical LLC | 43 | $1,830 |
| Abbott | 3 | $876 |
| Medtronic(2 entities) | 9 | $428 |
| Bard Peripheral Vascular, Inc. | 10 | $360 |
| Stryker | 11 | $342 |
| Johnson & Johnson | 11 | $286 |
| Cardiovascular Systems Inc. | 8 | $264 |
| Smith+Nephew | 7 | $225 |
| Shockwave Medical, Inc | 2 | $155 |
| Endologix LLC | 1 | $144 |
| Advanced Oxygen Therapy Inc. | 3 | $62 |
| Tactile Systems Technology Inc | 4 | $61 |
| Resmed Corp | 1 | $59 |
| Pfizer | 3 | $55 |
| Acell, Inc. | 1 | $44 |
| Boston Scientific | 2 | $36 |
| Bioventus LLC | 1 | $30 |
| Integra Lifesciences Corporation | 1 | $26 |
| Convatec Inc. | 1 | $25 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Cardinal Health 200 LLC | 1 | $13 |
| Next Science LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GLIDESHEATH SLENDER$44,777
- FLOWTRIEVER CATHETER, S$20,283
- CT THROMBECTOMY SYSTEM KIT$20,006
- Azur CX Detachable$16,180
- VenaCure 1470 Pro$14,280
- R2P MISAGO$10,009
- TR Band$9,900
- Zilver Vena$8,057
- Navicross$7,306
- GORE VIABAHN VBX Balloon Expandable Endo$3,285
- GlideWire$3,176
- TREO ABDOMINAL STENT-GRAFT SYSTEM$1,771
- IMPEDE EMBOLIZATION PLUG$1,690
- METACROSS OTW$1,510
- Zenith$1,500
- Diamondback Peripheral$853
- Zenith Spiral-Z$481
- Alto Abdominal Stent Graft System$144
- Grafts$139
- ENDURANT IIS$138
How this compares
$158,308 in reported general payments places this provider in the 95th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 57 | $40,353 |
| EliquisApixaban | 22 | $17,845 |
| SantylCollagenase Clostridium Hist. | 18 | $5,028 |
| ClopidogrelClopidogrel Bisulfate | 35 | $437 |
| Cilostazol | 12 | $209 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $286 | $40,35357 claims |
| PfizerEliquis | $55 | $17,84522 claims |
| Smith+NephewSantyl | $225 | $5,02818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 405 vascular surgery providers in New York.
Other vascular surgery in Bronx
- Saadat ShariffBronx$69K
- Gary GelbfishNew York$1.9M
- Sundaram RavikumarDobbs Ferry$1.8M
- Antonios GasparisHuntington$1.5M
- Sonya NoorBuffalo$991K
- John LantisNew York$922K
- Brian DerubertisNew York$714K
- James McKinseyNew York$616K
- Peter FariesNew York$494K
- Robert RheeBrooklyn$338K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.